Literature DB >> 17208031

[Chemoradiation for locally advanced non-small cell lung cancer].

N Girard1, F Mornex.   

Abstract

Chemoradiation is one of the major therapeutic options in thoracic oncology: besides surgery, the best treatment for early-stage tumors, and chemotherapy, not only used in metastatic tumors, but also in a neoadjuvant and adjuvant setting, chemoradiation is the standard strategy for unresectable locally advanced non-small cell lung cancer. Its current modalities include three-dimensional conformal techniques, allowing dose escalation and sequential and concurrent combination with new generation cytotoxic agents to occur. Phase III trials are currently evaluating the benefit from induction and consolidation chemotherapy in this setting. New techniques of radiation may also increase the efficacy and the feasibility of radiation. This constant progress makes chemoradiation one of the most promising combined treatments in thoracic oncology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208031     DOI: 10.1016/j.canrad.2006.11.002

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patients.

Authors:  Pierre Truntzer; Delphine N Antoni; Nicola Santelmo; Catherine Schumacher; Pierre-Emmanuel Falcoz; Elisabeth Quoix; Jean-Pierre Steib; Gilbert Massard; Georges Noël
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.